Your browser doesn't support javascript.
loading
Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage.
Scheepers, Cathrine; Everatt, Josie; Amoako, Daniel G; Tegally, Houriiyah; Wibmer, Constantinos Kurt; Mnguni, Anele; Ismail, Arshad; Mahlangu, Boitshoko; Lambson, Bronwen E; Martin, Darren P; Wilkinson, Eduan; San, James Emmanuel; Giandhari, Jennifer; Manamela, Nelia; Ntuli, Noxolo; Kgagudi, Prudence; Cele, Sandile; Richardson, Simone I; Pillay, Sureshnee; Mohale, Thabo; Ramphal, Upasana; Naidoo, Yeshnee; Khumalo, Zamantungwa T; Kwatra, Gaurav; Gray, Glenda; Bekker, Linda-Gail; Madhi, Shabir A; Baillie, Vicky; Van Voorhis, Wesley C; Treurnicht, Florette K; Venter, Marietjie; Mlisana, Koleka; Wolter, Nicole; Sigal, Alex; Williamson, Carolyn; Hsiao, Nei-Yuan; Msomi, Nokukhanya; Maponga, Tongai; Preiser, Wolfgang; Makatini, Zinhle; Lessells, Richard; Moore, Penny L; de Oliveira, Tulio; von Gottberg, Anne; Bhiman, Jinal N.
Afiliação
  • Scheepers C; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Everatt J; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, 2132, Johannesburg, South Africa.
  • Amoako DG; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Tegally H; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Wibmer CK; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.
  • Mnguni A; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, 7600, Stellenbosch, South Africa.
  • Ismail A; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Mahlangu B; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Lambson BE; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Martin DP; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Wilkinson E; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • San JE; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, 2132, Johannesburg, South Africa.
  • Giandhari J; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, 7925, Cape Town, South Africa.
  • Manamela N; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.
  • Ntuli N; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, 7600, Stellenbosch, South Africa.
  • Kgagudi P; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.
  • Cele S; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, 7600, Stellenbosch, South Africa.
  • Richardson SI; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.
  • Pillay S; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Mohale T; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, 2132, Johannesburg, South Africa.
  • Ramphal U; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Naidoo Y; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Khumalo ZT; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, 2132, Johannesburg, South Africa.
  • Kwatra G; Africa Health Research Institute, 4001, Durban, South Africa.
  • Gray G; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, 4041, Durban, South Africa.
  • Bekker LG; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Madhi SA; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, 2132, Johannesburg, South Africa.
  • Baillie V; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.
  • Van Voorhis WC; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Treurnicht FK; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.
  • Venter M; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.
  • Mlisana K; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, 7600, Stellenbosch, South Africa.
  • Wolter N; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • Sigal A; Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, 0110, Onderstepoort, South Africa.
  • Williamson C; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, 2000, Johannesburg, South Africa.
  • Hsiao NY; Department of Clinical Microbiology, Christian Medical College, Vellore, 632004, India.
  • Msomi N; South African Medical Research Council, 7505, Cape Town, South Africa.
  • Maponga T; Desmond Tutu HIV Centre, 7925, Cape Town, South Africa.
  • Preiser W; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, 2000, Johannesburg, South Africa.
  • Makatini Z; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, 2000, Johannesburg, South Africa.
  • Lessells R; Center for Emerging and Re-emerging Infectious Diseases (CERID), University of Washington, Washington, 98195, USA.
  • Moore PL; National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
  • de Oliveira T; Faculty of Health Sciences, University of the Witwatersrand, 2193, Johannesburg, South Africa.
  • von Gottberg A; Zoonotic Arbo and Respiratory Virus Research Programme, Department of Medical Virology, Faculty of Health, University of Pretoria, 0031, Gezina, South Africa.
  • Bhiman JN; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, 4041, Durban, South Africa.
Nat Commun ; 13(1): 1976, 2022 04 08.
Article em En | MEDLINE | ID: mdl-35396511
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article